S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
OTCMKTS:ERFSF

Eurofins Scientific (ERFSF) Stock Forecast, Price & News

$56.96
+1.25 (+2.24%)
(As of 09/29/2023 08:54 PM ET)
Compare
Today's Range
$56.96
$57.71
50-Day Range
$55.71
$70.00
52-Week Range
$55.60
$78.80
Volume
700 shs
Average Volume
1,556 shs
Market Capitalization
$10.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ERFSF stock logo

About Eurofins Scientific (OTCMKTS:ERFSF) Stock

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; and testing for persistent organic pollutants, dioxins and organic contaminants, pesticides, mycotoxins, allergens, and pathogens and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

ERFSF Price History

ERFSF Stock News Headlines

HSBC Lowers Eurofins Scientific (OTCMKTS:ERFSF) to Hold
Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
See More Headlines
Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Company Calendar

Today
10/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CIK
N/A
Employees
55,631
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.07 billion
Cash Flow
$6.52 per share
Book Value
$26.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.96 billion
Optionable
Not Optionable
Beta
0.73
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Gilles G. Martin Ph.D. (Age 60)
    Chairman & CEO
    Comp: $1.36M
  • Ms. Valerie Hanote (Age 57)
    Exec. Director
    Comp: $387.06k
  • Mr. Laurent Lebras
    Group Admin. & Fin. Director
  • Ms. Sandra Hoeylaerts
    Chief HR Officer
  • Mr. David W. Bryant
    Sr. VP of Strategic Bus. Devel. North America
  • Mr. Gabriel Julia
    Sr. VP of Clinical Diagnostics Europe
  • Dr. Timothy S. Oostdyk
    Exec. VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim Reichelt
    Sr. VP of Food & Feed Testing Europe
  • Ms. Yvoine Remy
    Sr. VP of Environment Testing Europe
  • Mr. Rajesh Saigal
    Exec. VP - Asia













ERFSF Stock - Frequently Asked Questions

Should I buy or sell Eurofins Scientific stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last twelve months. There are currently 3 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "strong sell" ERFSF shares.
View ERFSF analyst ratings
or view top-rated stocks.

How have ERFSF shares performed in 2023?

Eurofins Scientific's stock was trading at $72.3850 at the beginning of the year. Since then, ERFSF stock has decreased by 21.3% and is now trading at $56.9550.
View the best growth stocks for 2023 here
.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 302,100 shares, an increase of 15.6% from the August 15th total of 261,400 shares. Based on an average trading volume of 2,100 shares, the days-to-cover ratio is currently 143.9 days.
View Eurofins Scientific's Short Interest
.

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $56.96.

How much money does Eurofins Scientific make?

Eurofins Scientific (OTCMKTS:ERFSF) has a market capitalization of $10.96 billion and generates $7.07 billion in revenue each year.

How many employees does Eurofins Scientific have?

The company employs 55,631 workers across the globe.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The official website for the company is www.eurofins.com. The company can be reached via phone at (522) 618-5320, via email at ir@eurofins.com, or via fax at 352-2618-5331.

This page (OTCMKTS:ERFSF) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -